Some dominant RYR1-RM variants are allelic to the malignant hyperthermia susceptibility trait (MHS), which is a pharmacogenetics predisposition to malignant hyperthermia and severe adverse reactions to volatile anesthetics and muscle relaxants [58], and some of these imply an increased risk of MHS. This evidence concerns the gene RYR1 and Malignant hyperthermia.